Mitch C. Hill, Chief Financial Officer at Inari Medical, Inc. (NARI), sold 22,400 shares at $69.93 ($1.6M) on 2023-05-12, disclosed to the SEC on 2023-05-16.
Scheduled sale ($1.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.93 | 3,400 | $238K | 15.1% |
| 2 | $69.93 | 3,400 | $238K | 15.1% |
| 3 | $69.96 | 3,729 | $261K | 16.6% |
| 4 | $69.96 | 3,729 | $261K | 16.6% |
| 5 | $70.63 | 3,100 | $219K | 13.9% |
| 6 | $70.69 | 2,521 |
| $178K |
| 11.3% |
| 7 | $70.69 | 2,521 | $178K | 11.3% |
| Total | $70.21 avg | 22,400 | $1.6M | 100% |
| Filing → |
| NARI | SELL | 2024-07-16 | $540K | — | Filing → |
| NARI | SELL | 2024-06-14 | $476K | — | Filing → |
| NARI | SELL | 2024-05-15 | $276K | — | Filing → |